ENGLISH
|
JAPANESE
|
CONNECT WITH US:
Home
About
Contact
Log in
*
Home
Press release
2020年01月30日 09時00分
Source:
Eisai
エーザイ、中国における新型コロナウイルス関連肺炎への対応活動支援について
東京, 2020年01月30日 - (JCN Newswire) - エーザイ株式会社（本社：東京都、代表執行役 CEO：内藤晴夫）は、このたび、中華人民共和国（以下、中国）の湖北省武漢市を中心に感染が広がっている新型コロナウイルス関連肺炎について、現地での対応活動を支援するため、当社の中国子会社を通じて、非営利団体である武漢市慈善総会（武汉市慈善总会）に100万元（日本円で約1600万円）の義援金を寄付することを決定しました。また、現地の医療機関に対して、医薬品の提供を行います。
中国における新型コロナウイルス関連肺炎患者様の早期回復と感染の終息を心より祈念いたします。
本リリースの詳細は下記をご参照ください。
https://www.eisai.co.jp/news/2020/news202007.html
概要：エーザイ株式会社
詳細は www.eisai.co.jp をご覧ください。
Source: Eisai
セクター: バイオテック
Copyright ©2025 JCN Newswire. All rights reserved. A division of Japan Corporate News Network.
Latest Release
Team Mitsubishi Ralliart Conducts Shakedown Ahead of Asia Cross Country Rally 2025: Targeting First Overall Championship in Three Years
Aug 07, 2025 18:40 JST
Toyota to Establish New Vehicle Manufacturing Plant in Japan
Aug 07, 2025 18:31 JST
MHI Heat Pumps NZ Wins People's Choice Award for Third Year Running
Aug 07, 2025 17:32 JST
FWD Group completes build-out of high-net-worth hub in Asia
Aug 07, 2025 14:00 JST
Shoucheng Highlights VC Role and Robot Lineup at WRC 2025
Aug 07, 2025 10:50 JST
Fastport eQuad, Flagship Product from New Honda Business Venture, Wins "Red Dot: Best of the Best 2025" Award in Red Dot Award: Design Concept
Aug 06, 2025 19:40 JST
Dream Incubator and DENSO Launch Demonstration Project for Digital Platform Development for Mobility Circular Economy and Integrated Manufacturing for India
Aug 06, 2025 18:54 JST
Fujitsu's CHRO Roundtable Report 2025 highlights data-driven HRBP practices for human capital management
Aug 06, 2025 11:00 JST
MHI Selected to Enter Next Stage Procurement Process for Australia's New General-Purpose Frigates
Aug 05, 2025 22:02 JST
12 New Companies Join Toyota Woven City as Inventors
Aug 04, 2025 21:09 JST
Honda HRC Wins 46th Suzuka 8 Hours Endurance Road Race
Aug 04, 2025 20:43 JST
MUFG Bank and Fujitsu collaborate on preventive health ecosystem to address societal challenges
Aug 04, 2025 11:00 JST
Hitachi completes capital reorganization of air conditioning joint venture accelerating the deployment of green cooling solutions through "One Hitachi"
Aug 01, 2025 19:00 JST
Mitsubishi Motors and Security Bank launch Mitsubishi Motors Finance Philippines Inc.
Aug 01, 2025 17:00 JST
Honda Turkiye A.S. decided to establish Motorcycle Production Factory
Aug 01, 2025 16:45 JST
Honda Begins Joint Demonstration of Stationary Fuel Cell Power Station Designed to Utilize By-product Hydrogen and Repurposed Automotive Fuel Cells
Aug 01, 2025 11:20 JST
Isuzu's first battery-electric pickup "D-MAX EV" adopts eAxle
Aug 01, 2025 11:00 JST
Fujitsu starts official development of plus-10,000 qubit superconducting quantum computer targeting completion in 2030
Aug 01, 2025 10:20 JST
Revenue of LEQEMBI(R) (Preliminary Basis)
Jul 31, 2025 18:27 JST
Transfer of Sharp Mie Plant No.2 and part of the land at Mie Base
Jul 31, 2025 17:11 JST
More Latest Release >>
Related Release
Revenue of LEQEMBI(R) (Preliminary Basis)
7/31/2025 6:27:00 PM JST
Early Alzheimer's Patients Continue to Benefit from Four Years of LEQEMBI(R) (lecanemab-irmb) Therapy New Clinical Data Presented at AAIC
7/31/2025 9:30:00 AM JST
New Data Presented at AAIC Demonstrates Investigational LEQEMBI(R) (lecanemab-irmb) 360 mg Subcutaneous Maintenance Dosing Could Offer a New Option for Ongoing Treatment of Early Alzheimer's Disease
7/31/2025 9:20:00 AM JST
Two-Year Real-World Study of LEQEMBI(R) in the United States Presented at Alzheimer's Association International Conference (AAIC) 2025
7/31/2025 9:10:00 AM JST
LENVIMA(R) (lenvatinib) in Combination with Pembrolizumab and Transarterial Chemoembolization (TACE) Approved in China for the Treatment of Unresectable, Non-Metastatic Hepatocellular Carcinoma
7/29/2025 9:01:00 AM JST
Eisai Listed for 24th Consecutive Year in FTSE4Good Index Series, an Index for Socially Responsible Investment
7/25/2025 1:31:00 PM JST
Launch of Beova(R) Tablets in Thailand for Overactive Bladder
7/23/2025 10:07:00 AM JST
Eisai To Present Four-Year Efficacy And Safety Data On Continuous Treatment With Lecanemab At The Alzheimer's Association International Conference 2025
7/22/2025 11:56:00 AM JST
Eisai Awarded "The 9th Bioindustry Award" for Drug Discovery Research for Anti- Amyloid B Monoclonal Antibody Lecanemab
7/16/2025 2:50:00 PM JST
"URECE" (Dotinurad) Launched in China as a treatment for Gout
7/14/2025 10:20:00 AM JST
More Press release >>